Removing Incentives To Lower Drug Prices Isn’t Pharma ‘Reform’

Tuesday, January 14th 2025, 12:37:28 pm
article
Delinking legislation is a giveaway to the pharmaceutical industry that will prove costly to taxpayers and Part D enrollees.
Breaking
More major Pentagon reshuffling is coming down the line, driven by Secretary of War Pete Hegseth, but this time it's being reported this will involve far...
The $0.1310–$0.1315 zone is now a resistance area, with further downside likely if volume remains high on declines....
The move followed multiple failed attempts to sustain momentum above recent resistance, leaving XRP vulnerable once support levels were tested again....
loading...